Genprex Stock Price

0.04 (1.38%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Genprex Inc GNPX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.38% 2.93 00:00:05
Open Price Low Price High Price Close Price Prev Close
2.93 2.86 3.10 2.96 2.89
Bid Price Ask Price Spread News
2.84 3.50 0.66 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,035 480,650 $ 2.97 $ 1,426,539 - 2.80 - 7.72
Last Trade Time Type Quantity Stock Price Currency
19:52:38 1 $ 3.10 USD


Draw Mode:

Genprex Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 138.78M 47.36M 45.10M $ - $ - -0.53 -6.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 112.13k 1.30%

more financials information »

Genprex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GNPX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.233.232.842.95476,958-0.30-9.29%
1 Month3.403.402.803.06477,670-0.47-13.82%
3 Months3.464.072.803.43605,362-0.53-15.32%
6 Months4.607.722.804.74971,052-1.67-36.3%
1 Year3.427.722.804.311,024,836-0.49-14.33%
3 Years3.407.720.2313.271,325,202-0.47-13.82%
5 Years4.6919.44990.2313.441,219,052-1.76-37.53%

Genprex Description

Genprex Inc is a clinical-stage gene therapy company. It is focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who have limited treatment options. It works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies to provide novel treatment approaches for patients with cancer and diabetes.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.